ATE312635T1 - Ventilanordnung - Google Patents

Ventilanordnung

Info

Publication number
ATE312635T1
ATE312635T1 AT01909634T AT01909634T ATE312635T1 AT E312635 T1 ATE312635 T1 AT E312635T1 AT 01909634 T AT01909634 T AT 01909634T AT 01909634 T AT01909634 T AT 01909634T AT E312635 T1 ATE312635 T1 AT E312635T1
Authority
AT
Austria
Prior art keywords
valve arrangement
arrangement
valve
patient
providing
Prior art date
Application number
AT01909634T
Other languages
English (en)
Inventor
Ignacio Larrain
Michael Jedwab
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE312635T1 publication Critical patent/ATE312635T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16877—Adjusting flow; Devices for setting a flow rate
    • A61M5/16881—Regulating valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6045—General characteristics of the apparatus with identification means having complementary physical shapes for indexing or registration purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A61M39/24—Check- or non-return valves
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/7722—Line condition change responsive valves
    • Y10T137/7837—Direct response valves [i.e., check valve type]
    • Y10T137/7838—Plural

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Fluid Mechanics (AREA)
  • Physics & Mathematics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetically Actuated Valves (AREA)
  • Compressor (AREA)
AT01909634T 2000-01-20 2001-01-17 Ventilanordnung ATE312635T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0001309A GB0001309D0 (en) 2000-01-20 2000-01-20 Valve arrangement
PCT/EP2001/000450 WO2001052921A2 (en) 2000-01-20 2001-01-17 Valve arrangement

Publications (1)

Publication Number Publication Date
ATE312635T1 true ATE312635T1 (de) 2005-12-15

Family

ID=9884033

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01909634T ATE312635T1 (de) 2000-01-20 2001-01-17 Ventilanordnung

Country Status (6)

Country Link
US (1) US6843780B2 (de)
EP (1) EP1251894B1 (de)
AT (1) ATE312635T1 (de)
DE (1) DE60115842D1 (de)
GB (1) GB0001309D0 (de)
WO (1) WO2001052921A2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
US7094216B2 (en) 2000-10-18 2006-08-22 Medrad, Inc. Injection system having a pressure isolation mechanism and/or a handheld controller
EP1587482A4 (de) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation Entzündungshemmende zusammensetzungen und ihre verwendungen
EP1636333A4 (de) * 2003-06-19 2007-10-24 Evogene Ltd Nukleotidsequenzen zur regulation der genexpression in pflanzentrichomen sowie diese verwendende konstrukte und verfahren
US8129514B2 (en) 2003-06-19 2012-03-06 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
JP2007532234A (ja) * 2004-04-12 2007-11-15 メドラッド インコーポレーテッド 流体搬送システム、圧力隔離機構、インジェクタ制御機構、及びそれらを用いる方法
CA2588087A1 (en) * 2004-11-15 2006-05-18 Obe Therapy Biotechnology S.A.S. Methods of reducing body fat
US9433730B2 (en) 2013-03-14 2016-09-06 Bayer Healthcare Llc Fluid mixing control device for a multi-fluid delivery system
US9011377B2 (en) 2008-11-05 2015-04-21 Bayer Medical Care Inc. Fluid mixing control device for a multi-fluid delivery system
US7766883B2 (en) 2007-10-30 2010-08-03 Medrad, Inc. System and method for proportional mixing and continuous delivery of fluids
EP1901622B1 (de) 2005-05-23 2014-07-16 Intercontinental Great Brands LLC Geschmacksverstärkerzusammensetzungen und diese enthaltende getränke
WO2006131115A1 (en) * 2005-06-04 2006-12-14 Danfoss A/S Connector for a flow system
US20070225242A1 (en) * 2005-06-21 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for treating and preventing tumor metastasis in vivo
ES2435774T3 (es) * 2005-07-07 2013-12-23 Yissum Research Development Company, Of The Hebrew University Of Jerusalem Agentes de ácido nucleico para la regulación negativa de H19, y métodos de uso del mismo
US20080097389A1 (en) * 2006-07-10 2008-04-24 Wilson Roland B Y-type blood transfusion set
WO2008087641A2 (en) * 2007-01-16 2008-07-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem H19 silencing nucleic acid agents for treating rheumatoid arthritis
IL184627A0 (en) 2007-07-15 2008-12-29 Technion Res & Dev Foundation Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
ES2700141T3 (es) 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
AU2009298802A1 (en) 2008-09-23 2010-04-08 Alnylam Pharmaceuticals, Inc. Chemical modifications of monomers and oligonucleotides with cycloaddition
WO2010080769A2 (en) * 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
US8052656B2 (en) * 2009-02-10 2011-11-08 Tyco Healthcare Group Lp Enteral feeding system
US20100286650A1 (en) * 2009-05-07 2010-11-11 Alan Fitzgerald Medical Fluid Container
BR112012008084A2 (pt) * 2009-08-21 2019-09-24 Gilead Biologics Inc método terapêuticos e composições.
NZ625850A (en) * 2009-08-21 2015-12-24 Gilead Biologics Inc Methods and compositions for treatment of pulmonary fibrotic disorders
WO2011022709A1 (en) * 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vitro screening assays
WO2011022670A1 (en) * 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vivo screening assays
SG178845A1 (en) * 2009-08-21 2012-04-27 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
MX2012002189A (es) 2009-08-21 2012-03-16 Beeologics Inc Prevencion y cura de las enfermedades de los insectos beneficiosos a traves de moleculas.
WO2011030332A2 (en) 2009-09-08 2011-03-17 Yeda Research And Development Co. Ltd. Methods for hematopoietic precursor mobilization
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
EP3272869B1 (de) 2009-10-14 2020-06-24 Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. Zusammensetzungen zur bekämpfung von varroa-milben bei bienen
BR112012019693A2 (pt) 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
RU2012148398A (ru) 2010-04-18 2014-05-27 Иеда Рисеч Энд Девелопмент Ко. Лтд. МОЛЕКУЛЫ И СПОСОБЫ ПРИМЕНЕНИЯ МОЛЕКУЛ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕЙ, АССОЦИИРОВАННЫХ С ErbB/ErbB ЛИГАНДАМИ
WO2011133868A2 (en) 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. Conformationally restricted dinucleotide monomers and oligonucleotides
US10913767B2 (en) 2010-04-22 2021-02-09 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising acyclic and abasic nucleosides and analogs
WO2011158243A2 (en) 2010-06-16 2011-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of diagnosing and treating cancer
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
CN103210082A (zh) 2010-09-15 2013-07-17 雷蒙特亚特特拉维夫大学有限公司 扩增胰岛β细胞和使其再分化的方法
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
EP2627766B1 (de) 2010-10-17 2016-05-25 Yeda Research and Development Co. Ltd. Verfahren und zusammensetzungen zur behandlung von insulinassoziierten erkrankungen
US9415103B2 (en) 2011-06-14 2016-08-16 Yeda Research And Development Co. Ltd. Combination therapy to prevent DCIS formation and progression to breast cancer
EP2741753A2 (de) 2011-08-09 2014-06-18 Yeda Research and Development Co. Ltd. Herunterregulierung von mir-7 zur förderung der beta-zellen-differenzierung und insulinproduktion
US9617331B2 (en) 2011-11-27 2017-04-11 Yeda Research And Development Co. Ltd. Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
EP2844745A2 (de) 2012-02-22 2015-03-11 Brainstem Biotec Ltd. Erzeugung von neuralen stammzellen und motorneuronen
RU2703498C2 (ru) 2013-07-19 2019-10-17 Монсанто Текнолоджи Ллс Композиции и способы борьбы с leptinotarsa
HUE070313T2 (hu) 2013-11-04 2025-05-28 Greenlight Biosciences Inc Ízeltlábú paraziták és kártevõfertõzöttség szabályozására szolgáló készítmények és eljárások
BR112016022711A2 (pt) 2014-04-01 2017-10-31 Monsanto Technology Llc composições e métodos para controle de pragas de inseto
US9345829B2 (en) * 2014-04-27 2016-05-24 Joe Lomick Infusion device for IV drugs that are incompatible to each other
RU2021123470A (ru) 2014-07-29 2021-09-06 Монсанто Текнолоджи Ллс Композиции и способы борьбы с насекомыми-вредителями
CN108064274A (zh) 2014-07-30 2018-05-22 耶达研究及发展有限公司 用于培养多能干细胞的培养基
WO2016030899A1 (en) 2014-08-28 2016-03-03 Yeda Research And Development Co. Ltd. Methods of treating amyotrophic lateral scleroses
WO2016079736A2 (en) 2014-11-17 2016-05-26 Yeda Research And Development Co. Ltd. Methods of treating diseases related to mitochondrial function
WO2016135732A1 (en) 2015-02-26 2016-09-01 Yeda Research And Development Co. Ltd. Method of promoting hair growth
CA3225867A1 (en) 2015-03-24 2016-09-29 Illumina, Inc. Methods, carrier assemblies, and systems for imaging samples for biological or chemical analysis
CN114716390A (zh) 2015-04-07 2022-07-08 Ela制药有限公司 用于治疗和/或预防细胞或组织坏死的组合物和方法
CN107683089B (zh) 2015-05-04 2021-03-16 孟山都技术公司 用于控制节肢动物寄生虫和害虫侵扰的组合物和方法
EP3294280A1 (de) 2015-05-11 2018-03-21 Yeda Research and Development Co., Ltd. Citrinhemmer zur behandlung von krebs
WO2016185457A1 (en) 2015-05-19 2016-11-24 Yeda Research And Development Co. Ltd. Methods of promoting lymphangiogenesis
EA201792547A1 (ru) 2015-05-21 2018-04-30 Иеда Рисеч Энд Девелопмент Ко. Лтд. Популяции бактерий для стимуляции состояния здоровья
ES2965461T3 (es) 2015-08-03 2024-04-15 Biokine Therapeutics Ltd Inhibidor de CXCR4 para el tratamiento del cáncer
AU2016372249A1 (en) * 2015-12-16 2018-06-28 Axium Mtech SA Valve arrangement for enteral feeding sets having multiple fluid sources
WO2017102621A1 (en) * 2015-12-16 2017-06-22 Nestec S.A. Valve arrangement for enteral feeding sets having multiple fluid sources
US10828318B2 (en) 2016-01-06 2020-11-10 Yeda Research And Development Co. Ltd. Compositions and methods for treating malignant, autoimmune and inflammatory diseases
US20190216891A1 (en) 2016-03-06 2019-07-18 Yeda Research And Development Co., Ltd. Method for modulating myelination
EP3723785A1 (de) 2017-12-17 2020-10-21 Yeda Research and Development Co. Ltd Komplexe modulatoren des cop9-signalosoms (csn) und deren verwendung
MX2020011570A (es) 2018-05-07 2020-11-24 Alnylam Pharmaceuticals Inc Administracion extrahepatica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119411A (en) * 1957-12-21 1964-01-28 Rau Swf Autozubehoer Valved t-pipe joint, particularly for windshield washing apparatus
US4210173A (en) * 1976-12-06 1980-07-01 American Hospital Supply Corporation Syringe pumping system with valves
US4573974A (en) * 1982-12-01 1986-03-04 Baxter Travenol Laboratories, Inc. Medical administration set enabling sequential delivery of two liquids at different flow rate
US4729401A (en) * 1987-01-29 1988-03-08 Burron Medical Inc. Aspiration assembly having dual co-axial check valves
US5356375A (en) * 1992-04-06 1994-10-18 Namic U.S.A. Corporation Positive pressure fluid delivery and waste removal system
US5354272A (en) * 1993-03-02 1994-10-11 Baxter International Inc. Improved injectate delivery system
US5738662A (en) * 1996-02-21 1998-04-14 Pacific Device/Avail Medical Products, Inc. Retrograde flow checked manifold for infusing medical fluids
DE19643360C1 (de) * 1996-10-21 1998-05-14 Jan Willem Marinus Ing Myers Membranventil in Drei-Wege-Ausführung, insbesondere für die medizintechnische Anwendung
IL120654A (en) 1997-04-11 2001-08-08 Nestle Sa Administration of two liquids to a patient

Also Published As

Publication number Publication date
WO2001052921A2 (en) 2001-07-26
WO2001052921A3 (en) 2002-01-31
DE60115842D1 (de) 2006-01-19
EP1251894B1 (de) 2005-12-14
GB0001309D0 (en) 2000-03-08
US20030017068A1 (en) 2003-01-23
US6843780B2 (en) 2005-01-18
EP1251894A2 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
ATE312635T1 (de) Ventilanordnung
BG108443A (en) Substituted oxazoliidinones for combinational therapy
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
TW200505901A (en) Muscarinic agonists
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
SE9702860D0 (sv) New use
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
GB0020504D0 (en) Therapeutic method
MY135460A (en) Method of stimulating hair growth using benzopyrans
SE0402507D0 (sv) Medicinsk lösning, förfarande för framställning och användning därav
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
SE0101256D0 (sv) Treatment of low back pain
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
DE602004025683D1 (de) Therapeutische zubereitung für autoimmune erkrankungen
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
UA40330A (uk) Спосіб лікування запальних захворювань пародонту
UA30840A (uk) Спосіб лікування гострого калькульозного пієлонефриту
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
UA33487A (uk) Спосіб лікування підгострих запалювальних захворювань придатків матки
UA4292U (uk) Спосіб лікування альвеолітів

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties